ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1139

Inhaled Nitrous Oxide Facilitates Access to Intra-Articular Corticosteroid Injections in Children with Juvenile Idiopathic Arthritis

Mercedes O. Chan1, Ruth Wyllie2 and H. E. Foster3, 1Department of Pediatrics, Division of Pediatric Rheumatology, University of British Columbia and British Columbia's Children's Hospital, Vancouver, BC, Canada, 2Paediatric Rheumatology, Newcastle Hospitals, NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom, 3Paediatric Rheumatology, Newcastle Hospitals NHS Foundation Trust, Great North Children's Hospital, Newcastle Upon Tyne, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: corticosteroids, joint procedures and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease of childhood affecting 1 in 1000 children. Medical management for arthritis often includes intra-articular corticosteroid injections. The inhalation of nitrous oxide (N2O) in painful procedures is widely recognised in adults, yet is underused in children and young people (CYP). N2O is quickly absorbed, having low solubility in water and fat, and rapidly eliminated from the body when inhalation stops. It is safe, fast-acting, and non-invasive, reducing apprehension and anxiety. The use of N2O has increased access for CYP requiring painful procedures such as joint injections (JIs) that may have previously required a general anaesthetic. We aimed to describe a population of children receiving JIs with N2O at our center and the wait time for JIs with N2O once a decision to inject was made.

Methods: Data was collected retrospectively from available charts of children receiving JIs with N2O from January 2002 to April 2012 at our centre. Demographics, number of JIs (including types of joints injected), and number of repeat JIs within a year were recorded. Time from decision point (DP) to JI was calculated for JIs performed in 2011-2012.

Results: 397 JIs with N2O on 292 occasions (140 males, 152 females) were performed from 2002-2012. The median age at time of JI was 13.78 (range 6.38 to 18.97 years). The median number of JIs performed with N2O per year was 24 (range 14-53). On 48 occasions JIs were performed subsequent to one done earlier that calendar year. The median number of repeat JIs per patient requiring them was 1.

From 2011-2012, 79 JIs were performed with N2O. The median number of days from a DP to a JI with N2O was 0 (range 0-87 days). 62 patients had JIs within 2 weeks; 11 between 2 and 4 weeks; 2 between 4 to 6 weeks; and, 3 after 6 weeks from DP. One patient receiving a JI after 6 weeks (87 days) from DP required imaging to confirm synovitis before proceeding with the procedure. Reasons for other JIs performed after 6 weeks from DP were unable to be elicited from charts. Documentation of a DP for JIs with N­2O was present in 77/79 patients (97.5%).

Joints most commonly injected were: knees (80.05%), ankles (14.4%), elbows (3.28%), wrists (1.26%), subtalar (0.5%), fingers (0.31%) and shoulders (0.20%). There were no major adverse events (including septic arthritis) reported.  An increase in trainee procedures was seen after 2009 consistent with the introduction of a paediatric rheumatology (PRh) training program.  

Conclusion: Use of N2O for JIs in children with JIA allows for expeditious, safe and efficient sedation and analgesia. At our centre, children assessed in clinic and who need JIs may be offered one at that visit, performed by the PRh team (clinician and nurse specialist).  This has benefits for clinical care (rapid access to the procedure); the patient and family (less time off school/college or work, no anaesthetic risk); health care costs (reduced need for day case access and theatre time); and, optimal use of resources (preferential access to general anaesthetic lists for younger children; or those requiring multiple JIs or use of image intensifiers; or, quick procedures reducing PRh time).


Disclosure:

M. O. Chan,
None;

R. Wyllie,
None;

H. E. Foster,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inhaled-nitrous-oxide-facilitates-access-to-intra-articular-corticosteroid-injections-in-children-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology